Jeanne Lenzer - Journalist Profile | Connect with top journalists

Beats

Biography

I am an independent medical investigative journalist and former Knight Science Journalism fellow. My book, The Danger Within Us: America's Untested, Unregulated Medical Device Industry and One Man's Battle to Survive It, will be published by Little, Brown December 12, 2017. I have been a regular contributor to the international medical journal, The BMJ, and my articles, reviews, and commentary have appeared in The New York Times Magazine, The Atlantic, The New Republic, Discover, Slate, Washington Monthly, The Scientist, The (London) Independent, USA Today, Newsweek Japan, Mother Jones, and many other outlets. I am interested in legal corruption, not individual wrong-doing but the sort of structural, cultural practices that undermine the public well-being.

Content

Total articles 99

• Available on paid plans

  Big Pharma Is Pushing Potentially Deadly Alzheimer’s Drugs

  By Jeanne Lenzer

  Feb. 01, 2025

• Available on paid plans

  The Deadly Secrets Behind “Breakthrough” Alzheimer’s Drugs

  By Jeanne Lenzer

  Jan. 28, 2025

• Available on paid plans

  New Alzheimer’s Drugs Shrink Your Brain - Is That Bad?

  By Jeanne Lenzer

  Jan. 28, 2025

As seen in

Company Info

The BMJ

BMJ, or British Medical Journal, is a prominent global healthcare knowledge provider established in 1840. The organization focuses on improving health worldwide by enhancing the creation and sharing of medical research, advancing clinical education, and advocating for high-quality healthcare. BMJ offers a variety of services and products for healthcare professionals, researchers, educators, and the public. This includes the BMJ Journal, which publishes original research and commentary on clinical practice and healthcare policy. They also provide educational resources and courses, digital platforms for disseminating healthcare information, and organize live events and conferences for networking and discussion among healthcare professionals. The company is led by CEO Chris Jones and is headquartered in London. BMJ serves a diverse audience, including healthcare professionals, researchers, educators, policymakers, and the general public, all of whom benefit from its extensive resources and advocacy efforts.